ENABLEX 7,5 MG COM REV LIB PROL CT BL AL/AL X 28
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1376401410034 -
GGREM
505614120040113 -
Código de barras
7895858015176
O que a fonte publica
- Detentor do registro
- ASPEN PHARMA INDÚSTRIA FARMACÊUTICA LTDA
- Princípios ativos
- BROMIDRATO DE DARIFENACINA
- Embalagem
- 7,5 MG COM REV LIB PROL CT BL AL/AL X 28
- Tipo de produto
- Novo
- Classe terapêutica
- G4D4 - PRODUTOS PARA INCONTINÊNCIA URINÁRIA
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "ENABLEX 7,5 MG COM REV LIB PROL CT BL AL/AL X 28",
"holder": "ASPEN PHARMA INDÚSTRIA FARMACÊUTICA LTDA",
"stripe": null,
"barcodes": [
"7895858015176"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "505614120040113",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "02.433.631/0001-20",
"priceRegime": "Regulado",
"productName": "ENABLEX",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "7,5 MG COM REV LIB PROL CT BL AL/AL X 28",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "225.21",
"icms-12": "255.92",
"icms-17": "271.34",
"icms-18": "274.65",
"icms-19": "278.04",
"icms-20": "281.51",
"icms-21": "285.08",
"icms-22": "288.73",
"icms-23": "292.48",
"icms-17.5": "272.98",
"icms-19.5": "279.76",
"icms-20.5": "283.28",
"icms-22.5": "290.59",
"icms-12-alc": "228.50",
"icms-17-alc": "242.27",
"icms-18-alc": "245.22",
"icms-19-alc": "248.25",
"icms-20-alc": "251.35",
"icms-21-alc": "254.53",
"icms-22-alc": "257.80",
"icms-23-alc": "261.14",
"withoutTaxes": "201.08",
"icms-17.5-alc": "243.73",
"icms-19.5-alc": "249.79",
"icms-20.5-alc": "252.93",
"icms-22.5-alc": "259.46"
},
"pisCofinsList": "Negativa",
"substanceText": "BROMIDRATO DE DARIFENACINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "302.11",
"icms-12": "343.31",
"icms-17": "363.99",
"icms-18": "368.43",
"icms-19": "372.98",
"icms-20": "377.64",
"icms-21": "382.42",
"icms-22": "387.32",
"icms-23": "392.35",
"icms-17.5": "366.19",
"icms-19.5": "375.29",
"icms-20.5": "380.01",
"icms-22.5": "389.82",
"icms-12-alc": "315.89",
"icms-17-alc": "334.92",
"icms-18-alc": "339.00",
"icms-19-alc": "343.19",
"icms-20-alc": "347.48",
"icms-21-alc": "351.87",
"icms-22-alc": "356.39",
"icms-23-alc": "361.01",
"withoutTaxes": "277.98",
"icms-17.5-alc": "336.94",
"icms-19.5-alc": "345.32",
"icms-20.5-alc": "349.66",
"icms-22.5-alc": "358.69"
},
"invalidBarcodes": [],
"activeSubstances": [
"BROMIDRATO DE DARIFENACINA"
],
"therapeuticClass": "G4D4 - PRODUTOS PARA INCONTINÊNCIA URINÁRIA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1376401410034",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "G4D4",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:505614120040113"